These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 16550519

  • 1. Response to peginterferon treatment in hepatitis C virus-associated splenic lymphoma with villous lymphocytes.
    Kanbay M, Selcuk H, Gur G, Dagli N, Karakus S, Yilmaz U.
    Am J Hematol; 2006 Apr; 81(4):304-5. PubMed ID: 16550519
    [No Abstract] [Full Text] [Related]

  • 2. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection.
    Hermine O, Lefrère F, Bronowicki JP, Mariette X, Jondeau K, Eclache-Saudreau V, Delmas B, Valensi F, Cacoub P, Brechot C, Varet B, Troussard X.
    N Engl J Med; 2002 Jul 11; 347(2):89-94. PubMed ID: 12110736
    [Abstract] [Full Text] [Related]

  • 3. Regression of splenic lymphoma after treatment of hepatitis C virus infection.
    Mazzaro C, Little D, Pozzato G.
    N Engl J Med; 2002 Dec 26; 347(26):2168-70; author reply 2168-70. PubMed ID: 12501232
    [No Abstract] [Full Text] [Related]

  • 4. Thrombotic microangiopathy complicating pegylated interferon treatment of hepatitis C infection.
    Iskander D, Wickremasinghe M, Bain BJ.
    Am J Hematol; 2011 Oct 26; 86(10):859. PubMed ID: 21630311
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas.
    Kelaidi C, Rollot F, Park S, Tulliez M, Christoforov B, Calmus Y, Podevin P, Bouscary D, Sogni P, Blanche P, Dreyfus F.
    Leukemia; 2004 Oct 26; 18(10):1711-6. PubMed ID: 15284859
    [Abstract] [Full Text] [Related]

  • 8. Shorter treatment for hepatitis C genotype 4 may be a possibility.
    Iqbal S, Mansour M, Cerulli MA.
    South Med J; 2008 Jan 26; 101(1):106. PubMed ID: 18176306
    [No Abstract] [Full Text] [Related]

  • 9. Shortened therapy for hepatitis C virus genotype 2 or 3--is less more?
    Liang TJ.
    N Engl J Med; 2007 Jul 12; 357(2):176-8. PubMed ID: 17625131
    [No Abstract] [Full Text] [Related]

  • 10. [High dosage induction brings new hope].
    MMW Fortschr Med; 2005 Dec 15; 147(51-52):68. PubMed ID: 16404784
    [No Abstract] [Full Text] [Related]

  • 11. Histological benefits of virological response to peginterferon alfa-2a monotherapy in patients with hepatitis C and advanced fibrosis or compensated cirrhosis.
    Everson GT, Balart L, Lee SS, Reindollar RW, Shiffman ML, Minuk GY, Pockros PJ, Govindarajan S, Lentz E, Heathcote EJ.
    Aliment Pharmacol Ther; 2008 Apr 01; 27(7):542-51. PubMed ID: 18208570
    [Abstract] [Full Text] [Related]

  • 12. Regression of splenic lymphoma after treatment of hepatitis C virus infection.
    Emens LA, Sulkowski MS.
    N Engl J Med; 2002 Dec 26; 347(26):2168-70; author reply 2168-70. PubMed ID: 12501855
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Interferon therapy for hepatitis B and C].
    Iino S.
    Nihon Rinsho; 2007 Feb 28; 65 Suppl 2 Pt. 1():559-63. PubMed ID: 17455681
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity?
    Saadoun D, Suarez F, Lefrere F, Valensi F, Mariette X, Aouba A, Besson C, Varet B, Troussard X, Cacoub P, Hermine O.
    Blood; 2005 Jan 01; 105(1):74-6. PubMed ID: 15353484
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of an escalating dose regimen of pegylated interferon alpha-2a plus ribavirin in the early phase of HCV reinfection after liver transplantation.
    Zimmermann T, Böcher WO, Biesterfeld S, Zimmermann A, Kanzler S, Greif-Higer G, Barreiros AP, Sprinzl MF, Wörns MA, Lohse AW, Mönch C, Otto G, Galle PR, Schuchmann M.
    Transpl Int; 2007 Jul 01; 20(7):583-90. PubMed ID: 17433090
    [Abstract] [Full Text] [Related]

  • 18. Co-infections. German doctors treat hepatitis C early, with some success.
    TreatmentUpdate; 2006 Jul 01; 18(5):3-4. PubMed ID: 17209229
    [No Abstract] [Full Text] [Related]

  • 19. Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV.
    Andriulli A, Mangia A.
    N Engl J Med; 2007 Oct 18; 357(16):1660; author reply 1661-2. PubMed ID: 17942881
    [No Abstract] [Full Text] [Related]

  • 20. HIV & hepatitis C: treatment.
    WORLD; 2002 May 18; (133):4-5. PubMed ID: 12064298
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.